skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,099  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: MEDLINE remove Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Systemic lupus erythematosus
Material Type:
Article
Add to My Research

Systemic lupus erythematosus

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2326-2338 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00398-2 ;PMID: 38642569

Full text available

2
Rethinking health policy: life expectancy and mortality in an era of polycrisis
Material Type:
Article
Add to My Research

Rethinking health policy: life expectancy and mortality in an era of polycrisis

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1956-1958 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00754-2 ;PMID: 38762310

Full text available

3
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2204-2256 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00685-8 ;PMID: 38762325

Full text available

4
Global Burden of Disease Study 2021 estimates: implications for health policy and research
Material Type:
Article
Add to My Research

Global Burden of Disease Study 2021 estimates: implications for health policy and research

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1958-1959 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00812-2 ;PMID: 38642567

Full text available

5
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2133-2161 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00757-8 ;PMID: 38642570

Digital Resources/Online E-Resources

6
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2100-2132 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2024 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00367-2 ;PMID: 38582094

Digital Resources/Online E-Resources

7
AI-enabled opportunistic medical scan interpretation
Material Type:
Article
Add to My Research

AI-enabled opportunistic medical scan interpretation

The Lancet (British edition), 2024-05, Vol.403 (10439), p.1842-1842 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00924-3 ;PMID: 38735291

Full text available

8
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial
Material Type:
Article
Add to My Research

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial

The Lancet (British edition), 2024-05, Vol.403 (10439), p.1855-1865 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00282-4 ;PMID: 38604212

Full text available

9
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
Material Type:
Article
Add to My Research

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1753-1765 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00413-6 ;PMID: 38604213

Full text available

10
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial
Material Type:
Article
Add to My Research

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1749-1749 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00354-4 ;PMID: 38704166

Full text available

11
Percutaneous coronary intervention for non-obstructive vulnerable plaques
Material Type:
Article
Add to My Research

Percutaneous coronary intervention for non-obstructive vulnerable plaques

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1724-1725 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00488-4 ;PMID: 38604207

Full text available

12
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply
Material Type:
Article
Add to My Research

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1752-1752 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00353-2 ;PMID: 38704171

Full text available

13
Housing: an overlooked social determinant of health
Material Type:
Article
Add to My Research

Housing: an overlooked social determinant of health

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1723-1723 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00914-0 ;PMID: 38704156

Full text available

14
Rates and causes of death after release from incarceration among 1 471 526 people in eight high-income and middle-income countries: an individual participant data meta-analysis
Material Type:
Article
Add to My Research

Rates and causes of death after release from incarceration among 1 471 526 people in eight high-income and middle-income countries: an individual participant data meta-analysis

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1779-1788 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00344-1 ;PMID: 38614112

Full text available

15
10 years on: the legacy of the Flint water crisis
Material Type:
Article
Add to My Research

10 years on: the legacy of the Flint water crisis

The Lancet (British edition), 2024-04, Vol.403 (10437), p.1619-1620 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00860-2 ;PMID: 38679025

Full text available

16
The future of valvular heart disease assessment and therapy
Material Type:
Article
Add to My Research

The future of valvular heart disease assessment and therapy

The Lancet (British edition), 2024-04, Vol.403 (10436), p.1590-1602 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02754-X ;PMID: 38554727

Full text available

17
Heart valve disease: at the threshold of a new era in patient management
Material Type:
Article
Add to My Research

Heart valve disease: at the threshold of a new era in patient management

The Lancet (British edition), 2024-04, Vol.403 (10436), p.1519-1522 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00423-9 ;PMID: 38554723

Full text available

18
Coronary sinus reducer: a new hope for refractory angina?
Material Type:
Article
Add to My Research

Coronary sinus reducer: a new hope for refractory angina?

The Lancet (British edition), 2024-04, Vol.403 (10436), p.1514-1515 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00474-4 ;PMID: 38604208

Full text available

19
Valvular heart disease: from mechanisms to management
Material Type:
Article
Add to My Research

Valvular heart disease: from mechanisms to management

The Lancet (British edition), 2024-04, Vol.403 (10436), p.1576-1589 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02755-1 ;PMID: 38554728

Full text available

20
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
Material Type:
Article
Add to My Research

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

The Lancet (British edition), 2024-04, Vol.403 (10436), p.1543-1553 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00256-3 ;PMID: 38604209

Full text available

Results 1 - 20 of 3,099  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1965  (57)
  2. 1965 To 1979  (114)
  3. 1980 To 1994  (519)
  4. 1995 To 2010  (1,472)
  5. After 2010  (938)
  6. More options open sub menu

Language 

  1. Japanese  (406)
  2. Portuguese  (1)
  3. Norwegian  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait